Figure 1From: Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind studyAverage PEG-IFN concentration in serum. Data correspond to 15 healthy male subjects who received 180 μg of PEGASYS® (solid line) and 40-kDa PEG IFN alpha-2b (dashed line). Standard deviations are not shown for the sake of simplicity of the illustration.Back to article page